NCT00689156 Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer Status COMPLETED Phase PHASE3
NCT00688948 Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS) Status TERMINATED Phase PHASE2/PHASE3
NCT00688701 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy Status COMPLETED Phase PHASE3
NCT00687765 Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT00687687 Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma Status COMPLETED Phase PHASE2
NCT00687037 Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power Status COMPLETED Phase PHASE3
NCT00685958 Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery Status COMPLETED Phase PHASE3
NCT00681798 Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma Status COMPLETED Phase PHASE1
NCT00679900 Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties Status COMPLETED Phase PHASE3
NCT00679588 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery Status COMPLETED Phase PHASE3
NCT00679146 Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain Status COMPLETED Phase PHASE3
NCT00678483 Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients Status TERMINATED Phase PHASE3
NCT00677144 Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00677079 Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00675597 Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer Status COMPLETED Phase NA
NCT00674206 A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00670566 Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients Status COMPLETED Phase PHASE4